| 1 |
Systems biology approaches to adverse drug effects: the example of cardio-oncology |
|
| | Sherry-Ann Brown,Nicole Sandhu,Joerg Herrmann | | | Nature Reviews Clinical Oncology. 2015; 12(12): 718 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Significance of the expression of MRP1 and MRP2 in peripheral blood mononuclear cells of children with intractable epilepsy |
|
| | Xiaoming Liu,Xuan Yue,Shengzhi Chen,Jiao Chen,Rui Li | | | Experimental and Therapeutic Medicine. 2015; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Polymorphism of ABCB1/MDR1 C3435T in Children and Adolescents with Partial Epilepsy is due to Different Criteria for Drug Resistance – Preliminary Results |
|
| | Ksymena Urbanek | | | Medical Science Monitor. 2014; 20: 1654 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
FGF-2 protects cardiomyocytes from doxorubicin damage via protein kinase C-dependent effects on efflux transporters |
|
| | J. Wang,M. W. Nachtigal,E. Kardami,P. A. Cattini | | | Cardiovascular Research. 2013; 98(1): 56 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Mechanisms of action of antiepileptic drugs |
|
| | Aaron M Cook, Meriem K Bensalem-Owen | | | Therapy. 2011; 8(3): 307 | | | [HTML Full text] [Google Scholar] [DOI] | | | 6 |
Managing epilepsy in pregnancy |
|
| | Thomas, S.V. | | | Neurology India. 2011; 59(1): 59-65 | | | [Pubmed] [Google Scholar] | |
|
